What is the recommended follow‑up and surveillance protocol after treatment of a breast papillary lesion (papillomatosis)?

Follow-Up for Breast Papillomatosis

When core-needle biopsy confirms papilloma without atypia and imaging-pathology concordance is established, return immediately to routine annual screening mammography—no surgical excision or short-interval imaging is required. 1

Initial Management Decision Tree

Step 1: Confirm Radiologic-Pathologic Concordance

• Concordance must be verified first: the benign pathology must adequately explain the imaging abnormality (mass, calcifications, etc.). 1
• If concordant and no atypia present: proceed directly to annual surveillance without excision 1
• If discordant or indeterminate: surgical excision is mandatory to exclude missed malignancy 1

Step 2: Determine Need for Excision Based on Histology

Excision is required for:

• Papilloma with any atypia (atypical ductal hyperplasia, atypical lobular hyperplasia) 1, 2
• Radiologic-pathologic discordance 1
• Upgrade rate to malignancy is 22.72% when atypia is present on core biopsy 3
• When papilloma with atypia or ADH/ALH is found, >30% harbor concurrent invasive or in-situ carcinoma at excision 2

Excision is NOT required for:

• Papilloma without atypia when concordant with imaging 1
• Vacuum-assisted excision alone is sufficient if performed and complete 3, 4

Surveillance Protocol for Papilloma Without Atypia

Imaging Schedule

• Annual screening mammography starting immediately after diagnosis 1
• Do NOT perform 6-month short-interval follow-up imaging—studies show no benefit in cancer detection, stage, tumor size, or nodal status compared to annual screening 1
• Use screening (not diagnostic) mammography for asymptomatic follow-up 1

Imaging Modality Selection

• Standard 2D digital mammography or digital breast tomosynthesis (DBT) is appropriate 5
• DBT reduces recall rates and indeterminate findings without changing cancer detection rates 5
• MRI is NOT recommended for papilloma surveillance—proliferative lesions without atypia do not meet high-risk screening criteria 1

Duration of Surveillance

• Continue annual mammography indefinitely for all women ≥40 years 1
• Solitary papillomas without atypia carry insufficient increased malignancy risk to justify routine long-term follow-up beyond standard screening 6
• Multiple papillomas require lifelong annual surveillance due to increased bilateral breast cancer risk 6

Special Considerations for Multiple Papillomas (Papillomatosis)

• Higher malignancy risk than solitary papillomas—annual review with regular mammography is mandatory 6
• Digital mammography is preferred over analog due to better sensitivity 6
• Long-term follow-up is more appropriate than prophylactic mastectomy given the small, long-term, bilateral risk 6
• Conservative management with vacuum-assisted biopsy removal and surveillance shows no invasive cancers over 3.5-year median follow-up 7

Management of Papilloma With Atypia

If atypia is identified:

• Surgical excision with clear margins is mandatory 3
• Vacuum excision alone is insufficient when atypia is present 3
• Long-term cancer risk remains elevated even after excision—these patients require careful ongoing surveillance and should be considered for chemoprevention 2
• Annual mammographic surveillance continues indefinitely 2

Common Pitfalls to Avoid

• Do not schedule 6-month follow-up imaging for concordant papilloma without atypia—this increases false positives without improving outcomes 1
• Do not use diagnostic mammography for routine asymptomatic surveillance—screening mammography is sufficient and appropriate 1
• Do not skip concordance verification—discordant lesions require excision regardless of benign pathology 1
• Beware of apocrine cells that naturally exhibit enlarged nuclei mimicking malignancy—correlation with BI-RADS 2-3 imaging prevents unnecessary surgery 1
• Do not assume all papillomas are the same—multiple papillomas carry higher risk than solitary lesions and require different surveillance intensity 6